Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | insulin receptor | 0.0149 | 0.0129 | 0.0129 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0557 | 1 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0467 | 0.783 | 0.783 |
Schistosoma mansoni | tyrosine kinase | 0.0248 | 0.2529 | 0.2529 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0557 | 1 | 1 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0557 | 1 | 1 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0557 | 1 | 1 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0557 | 1 | 0.5 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0557 | 1 | 0.5 |
Loa Loa (eye worm) | TK/INSR protein kinase | 0.0149 | 0.0129 | 0.0129 |
Giardia lamblia | Kinase, TTK | 0.0144 | 0 | 0.5 |
Brugia malayi | Isocitrate dehydrogenase | 0.0557 | 1 | 1 |
Onchocerca volvulus | Dual specificity protein kinase TTK homolog | 0.0144 | 0 | 0.5 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0557 | 1 | 0.5 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.0467 | 0.783 | 0.783 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0149 | 0.0129 | 0.0129 |
Schistosoma mansoni | tyrosine kinase | 0.0149 | 0.0129 | 0.0129 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0557 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0144 | 0 | 0.5 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0557 | 1 | 0.5 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0557 | 1 | 0.5 |
Echinococcus multilocularis | insulin receptor | 0.0149 | 0.0129 | 0.0129 |
Brugia malayi | Furin-like cysteine rich region family protein | 0.0467 | 0.783 | 0.783 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0557 | 1 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0144 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0557 | 1 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0149 | 0.0129 | 0.0129 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0251 | 0.2593 | 0.2593 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0251 | 0.2593 | 0.2593 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0557 | 1 | 0.5 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0557 | 1 | 1 |
Echinococcus multilocularis | 0.0145 | 0.0015 | 0.0015 | |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0557 | 1 | 1 |
Echinococcus granulosus | melanoma receptor tyrosine protein kinase | 0.0251 | 0.2593 | 0.2593 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0467 | 0.783 | 0.783 |
Schistosoma mansoni | tyrosine kinase | 0.0248 | 0.2529 | 0.2529 |
Schistosoma mansoni | tyrosine kinase | 0.0251 | 0.2593 | 0.2593 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0557 | 1 | 0.5 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0557 | 1 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0251 | 0.2593 | 0.2593 |
Schistosoma mansoni | tyrosine kinase | 0.0248 | 0.2529 | 0.2529 |
Echinococcus granulosus | insulin growth factor 1 receptor beta | 0.0149 | 0.0129 | 0.0129 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0467 | 0.783 | 0.783 |
Schistosoma mansoni | tyrosine kinase | 0.0149 | 0.0129 | 0.0129 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0557 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 100 ug ml-1 | Antimicrobial activity against Candida albicans after 72 to 96 hr by two-fold serial dilution method | ChEMBL. | No reference |
MIC (functional) | = 100 ug ml-1 | Antimicrobial activity against Escherichia coli after 24 hr by two-fold serial dilution method | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.